Author:
Stevens A, ,Clayton P,Tatò L,Yoo H W,Rodriguez-Arnao M D,Skorodok J,Ambler G R,Zignani M,Zieschang J,Della Corte G,Destenaves B,Champigneulle A,Raelson J,Chatelain P
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology,Genetics,Molecular Medicine
Reference39 articles.
1. Park P, Cohen P . The role of insulin-like growth factor I monitoring in growth hormone-treated children. Horm Res 2004; 62 (Suppl 1): 59–65.
2. [No authors listed].. Critical evaluation of the safety of recombinant human growth hormone administration: statement from the Growth Hormone Research Society. J Clin Endocrinol Metab 2001; 86: 1868–1870.
3. Cohen P, Bright GM, Rogol AD, Kappelgaard AM, Rosenfeld RG . Effects of dose and gender on the growth and growth factor response to GH in GH-deficient children: implications for efficacy and safety. J Clin Endocrinol Metab 2002; 87: 90–98.
4. Cohen P, Germak J, Rogol AD, Weng W, Kappelgaard AM, Rosenfeld RG . Variable degree of growth hormone (GH) and insulin-like growth factor (IGF) sensitivity in children with idiopathic short stature compared with GH-deficient patients: evidence from an IGF-based dosing study of short children. J Clin Endocrinol Metab 2010; 95: 2089–2098.
5. Cohen P, Rogol AD, Howard CP, Bright GM, Kappelgaard AM, Rosenfeld RG . Insulin growth factor-based dosing of growth hormone therapy in children: a randomized, controlled study. J Clin Endocrinol Metab 2007; 92: 2480–2486.
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献